Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Total Current Liabilities (2019 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Total Current Liabilities for 7 consecutive years, with $252.1 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 44.01% to $252.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $252.1 million through Dec 2025, up 44.01% year-over-year, with the annual reading at $252.1 million for FY2025, 44.01% up from the prior year.
  • Total Current Liabilities hit $252.1 million in Q4 2025 for Harmony Biosciences Holdings, up from $223.4 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $252.1 million in Q4 2025 to a low of $33.4 million in Q1 2021.
  • Historically, Total Current Liabilities has averaged $120.1 million across 5 years, with a median of $109.9 million in 2022.
  • Biggest five-year swings in Total Current Liabilities: crashed 60.03% in 2021 and later skyrocketed 125.43% in 2022.
  • Year by year, Total Current Liabilities stood at $53.8 million in 2021, then skyrocketed by 46.69% to $78.9 million in 2022, then soared by 107.62% to $163.8 million in 2023, then grew by 6.9% to $175.1 million in 2024, then soared by 44.01% to $252.1 million in 2025.
  • Business Quant data shows Total Current Liabilities for HRMY at $252.1 million in Q4 2025, $223.4 million in Q3 2025, and $180.1 million in Q2 2025.